BTTC
Get informed when a big investor buys or sells
+ Follow| Market cap | $7.18 Million |
|---|---|
| Enterprise Value | $1.70 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.29 |
| Outstanding Shares | 3,857,906 |
| P/E Ratio | 17.09 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 634.45 |
| Enterprise Value to EBIT | 7605.78 |
| Enterprise Value to Net Income | 8109 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 1.43%▼ 14.13% |
|---|---|
| Total Invested | $77,089▼ 92.30% |
| Investors Holding | 11▼ 7.00% |
No data
Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.